Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Counsyl | RCV000665364 | SCV000789475 | uncertain significance | Alstrom syndrome | 2017-02-01 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000665364 | SCV001010355 | likely benign | Alstrom syndrome | 2024-10-02 | criteria provided, single submitter | clinical testing | |
Laboratory for Molecular Medicine, |
RCV001195320 | SCV001365659 | likely benign | not specified | 2017-08-23 | criteria provided, single submitter | clinical testing | p.Pro700Pro in exon 8 of ALMS1: This variant is not expected to have clinical significance because it does not alter an amino acid residue and is not located within the splice consensus sequence. It has been identified in 0.07% (6/8626) of East Asian chromosomes by the Exome Aggregation Consortium (ExAC, http://exac.broadinstitute.org; dbSNP rs750362630). |
Gene |
RCV001731859 | SCV001982036 | likely benign | not provided | 2021-04-01 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002422449 | SCV002726924 | likely benign | Cardiovascular phenotype | 2019-08-10 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Natera, |
RCV000665364 | SCV001453443 | likely benign | Alstrom syndrome | 2019-10-28 | no assertion criteria provided | clinical testing |